Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRANSFORM: Everolimus vs Mycophenolate in Renal Transplant
NCT01950819Phase 4Completed
- Sponsor
- Novartis
- Start
- Dec 2013
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 42
01
Overview
A Phase 4 trial of everolimus in kidney transplant rejection, sponsored by Novartis. Started Dec 2013; status: completed.
02
Drugs
everolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01950819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01950819.